This trial investigates whether combining atezolizumab (a drug that boosts the immune system) with bevacizumab (a drug that blocks blood vessel growth) can shrink tumors in people with advanced melanoma that cannot be removed by surgery or has spread. The study focuses on patient…
Phase: PHASE2 • Sponsor: F. Stephen Hodi, MD • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC